These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

145 related items for PubMed ID: 3711366

  • 1. Rapid antidepressant effect of addition of lithium to tranylcypromine.
    Tariot PN, Murphy DL, Sunderland T, Mueller EA, Cohen RM.
    J Clin Psychopharmacol; 1986 Jun; 6(3):165-7. PubMed ID: 3711366
    [Abstract] [Full Text] [Related]

  • 2. Addition of monoamine oxidase inhibitors to carbamazepine: preliminary evidence of safety and antidepressant efficacy in treatment-resistant depression.
    Ketter TA, Post RM, Parekh PI, Worthington K.
    J Clin Psychiatry; 1995 Oct; 56(10):471-5. PubMed ID: 7559374
    [Abstract] [Full Text] [Related]

  • 3. Efficacy of lithium-tranylcypromine treatment in refractory depression.
    Price LH, Charney DS, Heninger GR.
    Am J Psychiatry; 1985 May; 142(5):619-23. PubMed ID: 3920923
    [Abstract] [Full Text] [Related]

  • 4. [MAO-(monoamine oxidase-)inhibitor plus lithium. 1. Choice in psychopathologic rapidly changing bipolar manic-depressive patients (rapid cyclers)].
    Rogan M, Lesch OM, Schjerve M, Musalek M, Walter H.
    Wien Klin Wochenschr; 1983 Jul 08; 95(14):498-502. PubMed ID: 6636782
    [Abstract] [Full Text] [Related]

  • 5. Lithium potentiation of antidepressant treatment.
    Louie AK, Meltzer HY.
    J Clin Psychopharmacol; 1984 Dec 08; 4(6):316-21. PubMed ID: 6511998
    [Abstract] [Full Text] [Related]

  • 6. The use of lithium to augment antidepressant medication.
    Rouillon F, Gorwood P.
    J Clin Psychiatry; 1998 Dec 08; 59 Suppl 5():32-9; discussion 40-1. PubMed ID: 9635546
    [Abstract] [Full Text] [Related]

  • 7. [Comparison of the effectiveness of two treatment strategies in inpatients with a depressive disorder. A double-blind study of imipramine followed by lithium addition versus fluvoxamine followed by lithium addition].
    Birkenhäger TK, van den Broek WW, Mulder PG, Bruijn JA, Moleman P.
    Tijdschr Psychiatr; 2006 Dec 08; 48(4):271-81. PubMed ID: 16955991
    [Abstract] [Full Text] [Related]

  • 8. Treatment of depression in bipolar disorder: new directions for research.
    Zornberg GL, Pope HG.
    J Clin Psychopharmacol; 1993 Dec 08; 13(6):397-408. PubMed ID: 8120153
    [Abstract] [Full Text] [Related]

  • 9. Phenelzine treatment of melancholia.
    McGrath PJ, Stewart JW, Harrison W, Wager S, Quitkin FM.
    J Clin Psychiatry; 1986 Aug 08; 47(8):420-2. PubMed ID: 3525522
    [Abstract] [Full Text] [Related]

  • 10. Electrocardiographic effects of tranylcypromine vs. amitriptyline.
    White K, O'Leary J, Razani J, Rebal R, Palmer R.
    J Clin Psychiatry; 1983 Mar 08; 44(3):91-3. PubMed ID: 6833194
    [Abstract] [Full Text] [Related]

  • 11. Monoamine oxidase inhibitors in resistant major depression. A double-blind comparison of brofaromine and tranylcypromine in patients resistant to tricyclic antidepressants.
    Nolen WA, Haffmans PM, Bouvy PF, Duivenvoorden HJ.
    J Affect Disord; 1993 Jul 08; 28(3):189-97. PubMed ID: 8408980
    [Abstract] [Full Text] [Related]

  • 12. [Lithium in the treatment of depressed elderly patients].
    Bekker FM, van Marwijk HW, Nolen WA, Jansen PA, van Nieuwkerk JF.
    Ned Tijdschr Geneeskd; 1990 Mar 03; 134(9):442-5. PubMed ID: 2314507
    [Abstract] [Full Text] [Related]

  • 13. Lack of advantage for imipramine combined with lithium versus imipramine alone in the treatment of major depression--a double-blind controlled study.
    Shahal B, Piel E, Mecz L, Kremer I, Klein E.
    Biol Psychiatry; 1996 Dec 01; 40(11):1181-3. PubMed ID: 8931923
    [No Abstract] [Full Text] [Related]

  • 14. Efficacy and tolerability of tranylcypromine versus phenelzine: a double-blind study in antidepressant-refractory depressed inpatients.
    Birkenhäger TK, van den Broek WW, Mulder PG, Bruijn JA, Moleman P.
    J Clin Psychiatry; 2004 Nov 01; 65(11):1505-10. PubMed ID: 15554763
    [Abstract] [Full Text] [Related]

  • 15. Depression as a lethal disease: prevention strategies.
    Coppen A.
    J Clin Psychiatry; 1994 Apr 01; 55 Suppl():37-45. PubMed ID: 8077174
    [Abstract] [Full Text] [Related]

  • 16. Triiodothyronine potentiation of the antidepressant effect of phenelzine.
    Joffe RT.
    J Clin Psychiatry; 1988 Oct 01; 49(10):409-10. PubMed ID: 3170493
    [Abstract] [Full Text] [Related]

  • 17. [Monoamine oxidase inhibitors in the treatment of obsessive disorders. Two case reports and review of the literature].
    Erfurth A, Schmauss M.
    Nervenarzt; 1993 Jan 01; 64(1):70-2. PubMed ID: 8437650
    [Abstract] [Full Text] [Related]

  • 18. The addition of lithium to carbamazepine. Antidepressant efficacy in treatment-resistant depression.
    Kramlinger KG, Post RM.
    Arch Gen Psychiatry; 1989 Sep 01; 46(9):794-800. PubMed ID: 2505730
    [Abstract] [Full Text] [Related]

  • 19. Lithium augmentation in treatment-resistant depression: clinical evidence, serotonergic and endocrine mechanisms.
    Bschor T, Lewitzka U, Sasse J, Adli M, Köberle U, Bauer M.
    Pharmacopsychiatry; 2003 Nov 01; 36 Suppl 3():S230-4. PubMed ID: 14677084
    [Abstract] [Full Text] [Related]

  • 20. High dose tranylcypromine therapy for refractory depression.
    Amsterdam JD, Berwish NJ.
    Pharmacopsychiatry; 1989 Jan 01; 22(1):21-5. PubMed ID: 2710808
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.